20260618_BPTR_Ringkasan Risalah//Risalah RUPS_32102109_lamp2.pdf

    4. Determination of remuneration, salaries, honoraria, and other benefits for members of the Board of
       Directors and Board of Commissioners.
    5. Changes to the composition of the Company's Board of Directors.

Opportunity to Raise Questions and/or Opinions

For each agenda item, shareholders and/or their proxies were provided the opportunity to raise questions
and/or express opinions. One shareholder submitted a question and/or opinion for each agenda item.


Voting Mechanism

Resolutions were adopted through deliberation to reach consensus. In the absence of consensus,
resolutions would be adopted by voting.


Voting Results

First to Third Agenda Items


     • Votes in Favor : 3,186,126,973 shares
     • Abstentions : 100,000 shares
     • Votes Against : None

Fourth and Fifth Agenda Items


     • Votes in Favor : 3,186,126,573 shares
     • Abstentions : 100,400 shares
     • Votes Against : None

Accordingly, all resolutions were approved unanimously, taking into account the applicable provisions
regarding abstention votes under prevailing capital market regulations.


RESOLUTIONS OF THE MEETING

First Agenda Item

The Meeting approved and ratified the Company's Annual Report for the financial year ended 31 December
2025, including:


     • The Report of the Board of Directors regarding the Company's operations;
     • The Supervisory Report of the Board of Commissioners; and
     • The Company's Financial Statements for the financial year ended 31 December 2025.

The Meeting further granted full release and discharge (acquit et de charge) to all members of the Board of
Directors and Board of Commissioners for their management and supervisory actions undertaken during
the 2025 financial year, to the extent such actions were reflected in the Company's Annual Report and
Financial Statements.




                                                     2

Second Agenda Item

The Meeting approved the appropriation of the Company's net profit for the financial year ended 31
December 2025 as follows:


a. No cash dividend shall be distributed to shareholders.


b. An amount of IDR 400,000,000 (four hundred million Rupiah) shall be allocated as a statutory reserve in
accordance with the applicable laws and regulations.


c. The remaining balance shall be recorded as retained earnings to strengthen the Company's capital
structure and support future business development.


Third Agenda Item

The Meeting authorized the Board of Commissioners to appoint an independent Public Accountant and/or
Public Accounting Firm registered with the Financial Services Authority (OJK) to audit the Company's
Financial Statements for the financial year ending 31 December 2026.


The Board of Commissioners was also authorized to determine the audit fees and other appointment
terms, including the authority to appoint a replacement auditor if deemed necessary, after considering the
recommendation of the Audit Committee.


Fourth Agenda Item

The Meeting resolved:


a. To determine the remuneration and/or honoraria as well as other benefits for members of the Board of
Commissioners for the 2026 financial year at the same level as those approved for the 2025 financial year,
with any increase, if required, not exceeding 100% of the previous year's amount, and to authorize the
Board of Commissioners to determine the allocation among its members.


b. To authorize the Board of Commissioners to determine the remuneration, salaries, and other benefits for
members of the Board of Directors.


Fifth Agenda Item

The Meeting resolved:


a. To accept the resignation of Mrs. Rima Rupita from her position as Independent Director of the Company,
effective as of the closing of the Meeting, and to express appreciation for her dedication and contributions
during her tenure.


b. To appoint Mr. Kamal as Director of the Company, effective as of the closing of the Meeting.




                                                      3

c. Accordingly, the composition of the Company's Board of Directors, effective from the closing of the
Meeting until the closing of the Annual General Meeting of Shareholders in 2028, shall be as follows:


Board of Directors


     • President Director : Mr. Paulus Handigdo
     • Director : Mr. Kamal

d. To grant authority and power of attorney, with substitution rights, to the Board of Directors to state these
resolutions in a notarial deed, notify and/or obtain approval from the relevant authorities, and undertake all
actions necessary to implement the foregoing resolutions in accordance with the prevailing laws and
regulations.


Jakarta, 15 June 2026


PT Batavia Prosperindo Trans Tbk




                                                       4